Target Group Inc. (CBDY) financial statements (2021 and earlier)

Company profile

Business Address 55 ADMINISTRATION ROAD, UNIT 13
VAUGHAN, ON L4K-4G9
State of Incorp. DE
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17373133510921,778
Cash and cash equivalents17373133510921,778
Receivables34930182454111560
Inventory, net of allowances, customer advances and progress billings999999991241,0531,053
Inventory999999991241,0531,053
Prepaid expense4764636038110130
Advances on inventory purchases4343     
Other undisclosed current assets4541     
Total current assets:7551,2792472392131,3693,020
Noncurrent Assets
Operating lease, right-of-use asset101100101101   
Property, plant and equipment7,7947,7787,5947,3188,104449334
Long-term investments and receivables721162104    
Long-term investments721162104    
Intangible assets, net (including goodwill)3,6667,9347,7667,4608,14811,5039,297
Goodwill3,6667,9347,7667,4608,1489,2979,297
Intangible assets, net (excluding goodwill)     2,207 
Other noncurrent assets     11450
Other undisclosed noncurrent assets     7,7138,820
Total noncurrent assets:12,28215,97415,56414,87916,25219,78018,500
TOTAL ASSETS:13,03717,25215,81115,11816,46421,14921,520
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,8091,6391,5882,1772,4952,5454,021
Accrued liabilities1,002  1,1922,152692 
Interest and dividends payable404   54  
Settlement liabilities9060160    
Other undisclosed accounts payable and accrued liabilities3131,5791,4289862891,8534,021
Deferred revenue4343434343128 
Debt21822437843121
Deferred rent credit    262340343
Derivative instruments and hedges, liabilities1215151391518298
Due to related parties2,8322,3631,9061,067782386433
Other undisclosed current liabilities1761391601,4151,3251,175486
Total current liabilities:4,8734,1983,7945,0835,1354,6995,502
Noncurrent Liabilities
Long-term debt and lease obligation1,6221,5701,5561,51348  
Long-term debt, excluding current maturities    48  
Operating lease, liability1,6221,5701,5561,513   
Liabilities, other than long-term debt10,0519,7175,1882,7061,3471,3221,424
Deferred rent credit    1,3471,3221,424
Due to related parties7,1037,071     
Derivative instruments and hedges, liabilities2,9482,6465,1882,706   
Other undisclosed noncurrent liabilities104070  500 
Total noncurrent liabilities:11,68411,3276,8144,2191,3941,8221,424
Total liabilities:16,55715,52510,6079,3036,5296,5216,926
Stockholders' equity
Stockholders' equity attributable to parent, including:(3,521)1,7275,2045,8159,93514,62814,594
Preferred stock0000000
Common stock57575656575754
Common stock, share subscribed but unissued, subscriptions receivable    (220)  
Additional paid in capital23,94123,94123,68223,48129,84629,61828,310
Accumulated other comprehensive loss(1,175)(1,287)(1,467)(1,937)(897)(2,118)(2,159)
Accumulated deficit(26,536)(21,176)(17,259)(16,658)(19,463)(13,401)(12,416)
Other undisclosed stockholders' equity attributable to parent192192192872612471805
Other undisclosed stockholders' equity1    0(0)
Total stockholders' equity:(3,520)1,7275,2045,8159,93514,62814,594
TOTAL LIABILITIES AND EQUITY:13,03717,25215,81115,11816,46421,14921,520

Income statement (P&L) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues   30   
Cost of revenue
(Cost of Goods and Services Sold)
   (25)   
Gross profit:   5   
Operating expenses(445)(305)(234)(586)(1,152)(849)(1,644)
Other undisclosed operating loss    (151)  
Operating loss:(445)(305)(234)(581)(1,303)(849)(1,644)
Nonoperating income (expense)(4,916)(3,612)3673,386(4,896)(150)(537)
Foreign currency transaction gain (loss), before tax(49)(16)84(19)(606)(19)14
Interest and debt expense(81)(5,666)(2,398)(36)(468)(99)(811)
Income (loss) from continuing operations before equity method investments, income taxes:(5,441)(9,582)(2,266)2,769(6,666)(1,098)(2,992)
Other undisclosed income from continuing operations before income taxes815,6661,6643661999811
Income (loss) from continuing operations before income taxes:(5,361)(3,917)(601)2,805(6,048)(999)(2,181)
Income tax benefit     15 
Other undisclosed loss from continuing operations    (15)  
Net income (loss) available to common stockholders, diluted:(5,361)(3,917)(601)2,805(6,062)(985)(2,181)

Comprehensive Income ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(5,361)(3,917)(601)2,805(6,062)(985)(2,181)
Comprehensive income (loss):(5,361)(3,917)(601)2,805(6,062)(985)(2,181)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent112 470(1,040)1,22141(1,600)
Comprehensive income (loss), net of tax, attributable to parent:(5,249)(3,917)(132)1,766(4,841)(944)(3,781)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: